UK markets open in 1 hour 39 minutes

Morphic Holding, Inc. (MORF)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
27.69-1.06 (-3.69%)
At close: 04:00PM EDT
27.69 0.00 (0.00%)
After hours: 04:20PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close28.75
Open28.63
Bid27.61 x 100
Ask27.76 x 200
Day's range27.57 - 28.78
52-week range19.34 - 63.08
Volume323,927
Avg. volume494,512
Market cap1.386B
Beta (5Y monthly)1.42
PE ratio (TTM)N/A
EPS (TTM)-3.59
Earnings date24 Apr 2024 - 29 Apr 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est56.75
  • Zacks

    What Makes Morphic (MORF) a New Buy Stock

    Morphic (MORF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

  • Simply Wall St.

    Morphic Holding Insiders Placed Bullish Bets Worth US$47.3m

    Over the last year, a good number of insiders have significantly increased their holdings in Morphic Holding, Inc...

  • GlobeNewswire

    Morphic Appoints Dr. Simon Cooper as Chief Medical Officer

    Experienced Clinical Development Leader with Deep Experience in Immunology and Inflammatory DiseasesWALTHAM, Mass., March 19, 2024 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced that Simon Cooper, M.B.B.S., has joined the Company as Chief Medical Officer. Dr. Cooper is an accomplished leader in drug development with appreciable success and a p